The EMPOWER Study: Endometriosis Diagnosis Using MicroRNA (NCT04598698)
Endometriosis Diagnosis Using MicroRNA: Prospective Study in Women to Allow Early Disease Recognition
🩺 Plain-English Summary (8th-Grade Level)
Endometriosis is a complex, heterogeneous disease that may present inconsistently across women. Using disease-specific biomarkers and advanced biostatistics, DotLab is developing a biomarker test to confirm the presence of endometriosis.This is a multi-center, prospective, observational, minimal risk study in women undergoing laparoscopy, laparotomy or other pelvic surgical procedure for endometriosis, infertility or another benign gynecological indication. Participants will undergo 2 study visits for collection of blood and saliva and completion of study questionnaires.
Who can join: Review the eligibility criteria below.
Location: Stanford University Hospital — Palo Alto, California
Age range: 18 Years to 49 Years
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (23 Sites)
- Stanford University Hospital — Palo Alto, California
- Center for Special Minimally Invasive & Robotic Surgery — Woodside, California
- Yale University — New Haven, Connecticut
- Christiana Care — Newark, Delaware
- RAD Fertility — Newark, Delaware
- MedStar Washington Hospital Center — Washington D.C., District of Columbia
- University of South Florida — Tampa, Florida
- Academia of Women's Health and Endoscopic Surgery — Atlanta, Georgia
- Northwestern Medicine — Chicago, Illinois
- NorthShore University HealthSystem — Evanston, Illinois
- The Advanced Gynecologic Surgery Institute — Park Ridge, Illinois
- University of Louisville Hospital — Louisville, Kentucky
- Johns Hopkins University — Baltimore, Maryland
- Rutgers Robert Wood Johnson University Hospital — New Brunswick, New Jersey
- NewYork-Presbyterian / Columbia University Medical Center — New York, New York
- University Hospitals — Cleveland, Ohio
- Cleveland Clinic — Cleveland, Ohio
- University of Oklahoma Health Sciences Center — Oklahoma City, Oklahoma
- Penn State Health — Hershey, Pennsylvania
- Hospital of the University of Pennsylvania — Philadelphia, Pennsylvania
- University of Pittsburgh Medical Center — Pittsburgh, Pennsylvania
- UT Austin — Austin, Texas
- Seattle Reproductive Medicine — Seattle, Washington
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Endometriosis
- Nutritional Intervention for Endometriosis — Washington D.C., District of Columbia
- Evaluation of Endometriosis With 18F-fluorofuranylnorprogesterone PET / MRI — Chapel Hill, North Carolina
- Study Of Oral Elagolix Tablets In Combination With Combined Oral Contraceptive Capsules/Tablets To Assess Dysmenorrhea Response In Adult Female Participants With Endometriosis And Associated Moderate To Severe Pain — Anniston, Alabama
- Cancer Driving Mutations in Endometriosis Lesions and Development of Progesterone Resistance — New Haven, Connecticut
- Endometriosis and Health Care System Utilization in British Columbia — Vancouver, British Columbia
Explore by condition: All Endometriosis clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Review the official NIH record below to find the coordinating site.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.